8-[5-(Difluoromethyl)pyridin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)[1,2,4]triazolo[4,3-a]quinoxaline

ID: ALA4867528

PubChem CID: 164621831

Max Phase: Preclinical

Molecular Formula: C20H17F2N5O

Molecular Weight: 381.39

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  FC(F)c1cncc(-c2ccc3ncc4nnc(C5CCOCC5)n4c3c2)c1

Standard InChI:  InChI=1S/C20H17F2N5O/c21-19(22)15-7-14(9-23-10-15)13-1-2-16-17(8-13)27-18(11-24-16)25-26-20(27)12-3-5-28-6-4-12/h1-2,7-12,19H,3-6H2

Standard InChI Key:  KMVHNMPETPMFRJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   24.3410  -19.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3398  -20.6219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0520  -21.0350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0502  -19.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7630  -19.7947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7637  -20.6178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4764  -21.0290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1888  -20.6141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4708  -19.3844    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1830  -19.7849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7827  -19.2311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4452  -18.4909    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.6329  -18.5832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0765  -17.9796    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3284  -17.1958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7760  -16.5906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9728  -16.7635    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7250  -17.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2763  -18.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6311  -19.3900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6323  -18.5676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9212  -18.1551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2126  -18.5681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2154  -19.3936    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9229  -19.7983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9203  -17.3379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6276  -16.9286    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   22.2122  -16.9301    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8 10  1  0
  9  5  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 13 14  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
  1 20  1  0
 22 26  1  0
 26 27  1  0
 26 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4867528

    ---

Associated Targets(Human)

PRKDC Tchem DNA-dependent protein kinase (1929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATR Tchem ATR/ATRIP (56 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATM Tchem Serine-protein kinase ATM (4198 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CB Tchem PI3-kinase p110-beta subunit (4044 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SERPINA2 Tchem Putative alpha-1-antitrypsin-related protein (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.39Molecular Weight (Monoisotopic): 381.1401AlogP: 4.17#Rotatable Bonds: 3
Polar Surface Area: 65.20Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.01CX LogP: 1.35CX LogD: 1.35
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.53Np Likeness Score: -1.44

References

1. Berger M, Wortmann L, Buchgraber P, Lücking U, Zitzmann-Kolbe S, Wengner AM, Bader B, Bömer U, Briem H, Eis K, Rehwinkel H, Bartels F, Moosmayer D, Eberspächer U, Lienau P, Hammer S, Schatz CA, Wang Q, Wang Q, Mumberg D, Nising CF, Siemeister G..  (2021)  BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.,  64  (17.0): [PMID:34428039] [10.1021/acs.jmedchem.1c00762]

Source